SCHEMBL20737100

SCHEMBL20737100

CCn1c(-c2ccc(-c3ccc4cc5c(cc4c3)C3(c4ccccc4-c4ccccc43)c3ccc4ccccc4c3-5)cc2)nc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.44
ALDH1A1 P00352 11/20 0.44
HPGD P15428 7/20 0.44
HTT P42858 7/20 0.43
SMN1; SMN2 Q16637 6/20 0.43
MAPT P10636 6/20 0.43
NPSR1 Q6W5P4 4/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GFER P55789 1/20 0.43
NLRP3 Q96P20 1/20 0.38
LMNA P02545 3/20 0.37
TSHR P16473 2/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737645 0.95 KDM4E (0.41) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20737097 0.93 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20737719 0.91 KDM4E (0.54) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20737099 0.88 RAB9A (0.41) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL27250537 0.88 MAPT (0.47) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL20736547 0.88 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20736332 0.88 KDM4E (0.44) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20736625 0.87 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20737150 0.87 KDM4E (0.43) KDM4EALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL20736424 0.85 KDM4E (0.47) KDM4EALDH1A1HPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.